Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development - PubMed (original) (raw)
Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development
N C Luetteke et al. Development. 1999 Jun.
Abstract
Targeted mice lacking functional EGF or amphiregulin (AR) were derived and bred to the TGFalpha-knockout to generate mice lacking various combinations of the three ligands. In contrast to EGF receptor (EGFR) knockout mice, triple null mice lacking half of the EGFR ligand family were healthy and fertile, indicative of overlapping or compensatory functions among EGF family members. Nevertheless, pups born to triple null dams frequently died or were runted, suggesting a mammary gland defect. Comparison of individual and combinatorial knockouts established that specific loss of AR severely stunted ductal outgrowth during puberty, consistent with dramatic expression of AR transcripts in normal developing ducts. Surprisingly, loss of all three ligands did not significantly affect cellular proliferation, apoptosis, or ERK activation within terminal end buds. Following pregnancy, most AR single null females, but few triple null females could nurse their young, revealing collaborative roles for EGF and TGFalpha in mammopoiesis and lactogenesis. In triple null glands, alveoli were poorly organized and differentiated, and milk protein gene expression was decreased. Additionally, Stat5a activation was frequently reduced in AR single and combinatorial nulls in association with impaired lactation. Collectively, our results provide genetic confirmation of a requirement for EGFR signaling throughout the development of the mouse mammary gland, and reveal stage-dependent activities for different EGFR ligands. Finally, the additional loss of growth factors from pups nursed by triple null dams further worsened their survival and growth, establishing functions for both maternal- and neonatal-derived growth factors.
Similar articles
- Null mutation of peroxisome proliferator-activated receptor-interacting protein in mammary glands causes defective mammopoiesis.
Qi C, Kashireddy P, Zhu YT, Rao SM, Zhu YJ. Qi C, et al. J Biol Chem. 2004 Aug 6;279(32):33696-701. doi: 10.1074/jbc.M401266200. Epub 2004 May 25. J Biol Chem. 2004. PMID: 15161927 - The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
Riese DJ, Kim ED, Elenius K, Buckley S, Klagsbrun M, Plowman GD, Stern DF. Riese DJ, et al. J Biol Chem. 1996 Aug 16;271(33):20047-52. doi: 10.1074/jbc.271.33.20047. J Biol Chem. 1996. PMID: 8702723 - Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells.
Miyazaki Y, Hiraoka S, Tsutsui S, Kitamura S, Shinomura Y, Matsuzawa Y. Miyazaki Y, et al. Gastroenterology. 2001 Jan;120(1):108-16. doi: 10.1053/gast.2001.20950. Gastroenterology. 2001. PMID: 11208719 - TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase.
Lee DC, Sunnarborg SW, Hinkle CL, Myers TJ, Stevenson MY, Russell WE, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, Chang A, Jackson LF. Lee DC, et al. Ann N Y Acad Sci. 2003 May;995:22-38. doi: 10.1111/j.1749-6632.2003.tb03207.x. Ann N Y Acad Sci. 2003. PMID: 12814936 Review. - The type 1 (EGFR-related) family of growth factor receptors and their ligands.
Prigent SA, Lemoine NR. Prigent SA, et al. Prog Growth Factor Res. 1992;4(1):1-24. doi: 10.1016/0955-2235(92)90002-y. Prog Growth Factor Res. 1992. PMID: 1355372 Review.
Cited by
- Sprouty genes regulate activated fibroblasts in mammary epithelial development and breast cancer.
Li J, Ma R, Wang X, Lu Y, Chen J, Feng D, Zhou J, Xia K, Klein O, Xie H, Lu P. Li J, et al. Cell Death Dis. 2024 Apr 10;15(4):256. doi: 10.1038/s41419-024-06637-2. Cell Death Dis. 2024. PMID: 38600092 Free PMC article. - The BMAL1/HIF2A heterodimer modulates circadian variations of myocardial injury.
Ruan W, Li T, Lee J, Bang IH, Deng W, Ma X, Yoo SH, Kim B, Li J, Yuan X, An YA, Wang YY, Liang Y, Deberge M, Zhang D, Zhou Z, Wang Y, Gorham J, Seidman JG, Seidman CE, Aranki SF, Nair R, Li L, Narula J, Zhao Z, Abebe AG, Muehlschlegel JD, Tsai KL, Eltzschig HK. Ruan W, et al. Res Sq [Preprint]. 2024 Feb 28:rs.3.rs-3938716. doi: 10.21203/rs.3.rs-3938716/v1. Res Sq. 2024. PMID: 38464103 Free PMC article. Preprint. - Busting the Breast Cancer with AstraZeneca's Gefitinib.
Chemmalar S, Intan Shameha AR, Che Abdullah CA, Ab Razak NA, Yusof LM, Ajat M, Chan KW, Abu Bakar Zakaria MZ. Chemmalar S, et al. Adv Pharmacol Pharm Sci. 2023 Dec 4;2023:8127695. doi: 10.1155/2023/8127695. eCollection 2023. Adv Pharmacol Pharm Sci. 2023. PMID: 38090376 Free PMC article. Review. - LepR+ niche cell-derived AREG compromises hematopoietic stem cell maintenance under conditions of DNA repair deficiency and aging.
Wu L, Lin Q, Chatla S, Amarachintha S, Wilson AF, Atale N, Gao ZJ, Joseph J, Wolff EV, Du W. Wu L, et al. Blood. 2023 Nov 2;142(18):1529-1542. doi: 10.1182/blood.2022018212. Blood. 2023. PMID: 37584437 - Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma.
Hedegger K, Blutke A, Hommel T, Auer KE, Nataraj NB, Lindzen M, Yarden Y, Dahlhoff M. Hedegger K, et al. Mol Oncol. 2023 Nov;17(11):2415-2431. doi: 10.1002/1878-0261.13473. Epub 2023 Jul 14. Mol Oncol. 2023. PMID: 37341059 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous